placeholder image

EXAMINE Investigators All authors

About

Publications While At HealthPartners

selected publications

Journal Article

Alogliptin in patients with type 2 diabetes receiving metformin and sulfonylurea therapies in the EXAMINE Trial.

American Journal of Medicine. 2018

Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: the EXAMINE trial.

Diabetes, Obesity & Metabolism. 2017

Angiotensin-converting enzyme inhibitor use and major cardiovascular outcomes in type 2 diabetes mellitus treated with the dipeptidyl peptidase 4 inhibitor alogliptin.

Hypertension (Dallas, Tex.. 2016

Cardiovascular mortality in patients with type 2 diabetes and recent acute coronary syndromes from the EXAMINE Trial.

Diabetes care. 2016

Alogliptin after acute coronary syndrome in patients with type 2 diabetes.

New England Journal of Medicine. 2013

Abstract

Alogliptin in triple therapy with metformin and sulfonylureas provides significant reductions in HbA1c and is well tolerated: an analysis from the EXAMINE Trial [abstract].

Diabetes. 2016

Contact

full name

EXAMINE Investigators

Quick Info

Publications

Collaboration

Co-author network

Map of science